S Biomedics Co Ltd
KOSDAQ:304360
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
S Biomedics Co Ltd
KOSDAQ:304360
|
KR |
|
E
|
Empro Group Inc
NASDAQ:EMPG
|
MY |
|
A
|
AutoCrypt Co Ltd
KOSDAQ:331740
|
KR |
|
B
|
Bushido Capital Corp
XTSX:BUSH.P
|
CA |
|
V
|
Viet Duc Welding Electrode JSC
VN:QHD
|
VN |
|
Sanli Environmental Ltd
SGX:1E3
|
SG |
|
A
|
Adastra Holdings Ltd
SWB:D2E
|
CA |
|
A
|
Alseres Pharmaceuticals Inc
OTC:ALSE
|
US |
|
Authum Investment & Infrastructure Ltd
NSE:AIIL
|
IN |
|
Petrotal Corp
XTSX:TAL
|
US |
|
Jahwa Electronics Co Ltd
KRX:033240
|
KR |
|
E
|
Endor AG
XMUN:E2N
|
DE |
|
D
|
Doosan Skoda Power as
F:J3G
|
CZ |
|
G
|
Grandsys Inc
TPEX:6910
|
TW |
|
S
|
Sensor Technologies Corp
OTC:MOOIF
|
CA |
|
H
|
Hellenic Telecommunications Organization SA
XMUN:OTE
|
GR |
Bankruptcy Probability
S Biomedics Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
S Biomedics Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
S
|
S Biomedics Co Ltd
KOSDAQ:304360
|
245.7B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
232.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
S Biomedics Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, S Biomedics Co Ltd has total debt of 23.7B KRW. This includes both short-term (875m KRW) and long-term (22.8B KRW) debt.
You can find a full breakdown on its Balance Sheet.
